Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany.
Stachon P, Kaier K, Hehn P, Peikert A, Wolf D, Oettinger V, Staudacher D, Duerschmied D, Zirlik A, Zehender M, Bode C, von Zur Mühlen C.
Clin Res Cardiol. 2022 Jul;111(7):742-749. doi: 10.1007/s00392-021-01931-x. Epub 2021 Aug 28.
Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study.
Li Y, Hou X, Liu T, Xu S, Huang Z, Xu X, Dong R.
Front Cardiovasc Med. 2022 Apr 1;9:802181. doi: 10.3389/fcvm.2022.802181. eCollection 2022.
A comparison of drug-eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure.
Wang K, Wang L, Cong H, Zhang J, Hu Y, Zhang Y, Zhang R, Li W, Qi W.
ESC Heart Fail. 2022 Jun;9(3):1749-1755. doi: 10.1002/ehf2.13852. Epub 2022 Feb 22.
Coronary artery bypass grafting vs. drug-eluting stent implantation: the probabilities of reintervention, transition to severe care-need, nursing home, and death in patients with coronary artery disease within the first three years: evaluations based on health claims data in Germany.
Georges D, Kreft D, Doblhammer G.
J Thorac Dis. 2024 Aug 31;16(8):4863-4874. doi: 10.21037/jtd-24-251. Epub 2024 Aug 16.
Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial.
Fahrni G, Farah A, Engstrøm T, Galatius S, Eberli F, Rickenbacher P, Conen D, Mueller C, Pfister O, Twerenbold R, Coslovsky M, Cattaneo M, Kaiser C, Mangner N, Schuler G, Pfisterer M, Möbius-Winkler S, Jeger RV; BASKET‐SAVAGE‐Investigators*.
J Am Heart Assoc. 2020 Oct 20;9(20):e017434. doi: 10.1161/JAHA.120.017434. Epub 2020 Oct 9.
Three-Year Clinical and Angiographic Outcomes After Everolimus-Eluting Stent Implantation in Patients With a History of Coronary Artery Bypass Grafting.
Nomura T, Suzuki N, Takamura S, Kyono H, Kozuma K.
Int Heart J. 2016;57(2):158-66. doi: 10.1536/ihj.15-312. Epub 2016 Mar 11.
Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.
Chang M, Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, Han M, Park SW, Serruys PW, Park SJ.
Catheter Cardiovasc Interv. 2017 Aug 1;90(2):177-185. doi: 10.1002/ccd.26927. Epub 2017 Jan 23.
Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease.
Delhaye C, Sudre A, Lemesle G, Vanesson L, Koussa M, Fayad G, Bauters C, Lablanche JM, Modine T.
Arch Cardiovasc Dis. 2010 Oct;103(10):502-11. doi: 10.1016/j.acvd.2010.09.003. Epub 2010 Nov 10.
Propensity score-matched analysis of coronary artery bypass grafting versus second-generation drug-eluting stents for triple-vessel disease.
Nishigawa K, Fukui T, Hagiya K, Tobaru T, Uemura K, Takanashi S.
Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1152-1159. doi: 10.1093/ejcts/ezy415.
Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent.
Papadopoulos K, Avraamides P.
Case Rep Cardiol. 2021 Nov 5;2021:2360804. doi: 10.1155/2021/2360804. eCollection 2021.
